Pharmetheus: Advancing model informed drug development

Demands from payors and regulators for differentiated products necessitates creative integration of available data/information, with future trial data, to accelerate drug development in an efficient, cost effective and ethical manner.


  • has expertise in model informed drug development (MIDD) to support and inform study and program strategies and decisions..
  • has a track record of efficient delivery of fit for purpose solutions, including complex situations.
  • has access to a broad range of complementary drug research and development disciplines (including pharmacometrics, clinical pharmacology, statistics and regulatory) and academic subject matter experts.

Pharmetheus: transforming quality science to informed decisions

Drug development moves at a swift pace in an ever-changing competitive landscape and project teams are constantly facing new challenges, demanding a flexible proactive and adaptive mindset.


  • offers a broad range of fit for purpose analytical solutions, including data programming, across all phases of research and development (incorporating submission and post approval activities).
  • has a broad resource pool to accommodate varying needs, including modeling, training, interaction with regulatory bodies, expert advice and full-time equivalent support.
  • has experience of, and expertise in, a wide range of therapeutic areas.

Pharmetheus: when efficiency meets quality

Scientific rigor, quality, compliance and traceability are cornerstones in clinical drug development and regulatory submissions. This requires reliable technical solutions and experience to efficiently leverage MIDD in these settings.


  • has robust processes for reproducibility and documentation of analysis results.
  • has considerable experience of delivering submission ready reports.
  • has independent quality control (QC) to monitor and check on our deliverables.

About us

The nature and extent of services we provide is determined on the basis of client needs, from smaller projects aiming to support limited questions, to the larger late phase projects including submission support and post-marketing analyses. Our services are focused on drug usage and healthcare for a broad range of client types (pharmaceutical industry, charitable foundations, government and non-government agencies, not for profit organizations) and we also continuously contribute to technical research and methodological enhancements within the broader MIDD sector.

Pharmetheus currently has a team in excess of 45, located in a variety of countries globally, and we have not stopped growing.
Our staff members include modelers from diverse (but complementary) educational and technical backgrounds with extensive experience of both standard and complex analyses.  In collaboration with our scientific advisors, we use of cutting-edge tools and methodologies to enable fit for purpose deliverables for our clients. Our experienced consultants perform a range of quantitative approaches such as population PK, PKPD, PBPK and NCA analyses, as well as providing support for trial design optimization and expert advice in MIDD, clinical pharmacology, statistics, pharmacometrics and regulatory strategy across the product life-cycle. 

Pharmetheus has dedicated data programming support and we have developed systems, processes and tools employing state of the art project control processes to accommodate the dynamic nature of drug development organizations and allow for expedient delivery of even the largest projects.

At Pharmetheus we take considerable pride in our company values and our enthusiastic, dynamic and integrated team. Together these will ensure for our clients the supply of high quality and timely deliverables, compatible with the latest regulatory standards.